Ayble Health has raised $16 million in an oversubscribed Series A, led by Neon, bringing its total funding to more than $27 million. The virtual multidisciplinary GI care company says it now reaches 80+ million Americans through payer, employer and health-system partnerships and plans to use the funding to expand its AI-enabled precision care model and move into autoimmune conditions beyond GI.
Ayble’s model combines GI-trained providers, dietitians, behavioral health specialists, pharmacists, health coaches and care coordinators with proprietary technology and a large GI dataset. The company reports 16+ peer-reviewed studies and an average 47% improvement in GI symptoms, typically within four weeks and sustained for at least a year; these are company-reported outcomes.